RxDoctor Payments Data

Amber Williams

Family · Windsor, NCNPI 1780262311

Payments from drug & device makers

$691in general payments, 2019–2025

Across 37 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$126
  • Novo Nordisk$110
  • Dexcom, Inc.$109
  • Lilly USA, LLC$102
  • AbbVie$63
  • AstraZeneca$45
  • plus $135 from 5 others

What the payments were for

  • Food & beverage$691100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$691 in reported general payments places this provider in the 60th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$845
Medicare patients
41
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$37,120
FarxigaDapagliflozin Propanediol36$33,574
MounjaroTirzepatide28$28,429
JardianceEmpagliflozin28$22,657
OzempicSemaglutide16$19,745
JanuviaSitagliptin Phosphate20$19,728
TrulicityDulaglutide21$19,406
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$10,530
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$10,206
SymbicortBudesonide/Formoterol Fumarate31$7,596
Repatha SureclickEvolocumab12$6,337
Albuterol Sulfate HfaAlbuterol Sulfate93$2,808
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,560
Gabapentin106$2,386
Omeprazole142$2,242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$45$51,70082 claims
Lilly USA, LLCMounjaro, Trulicity$102$47,83549 claims
PfizerEliquis$44$37,12040 claims
Boehringer IngelheimJardiance$126$22,65728 claims
Novo NordiskOzempic$110$19,74516 claims
AbbVieSynthroid$63$72814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,522 family providers in North Carolina.

Other family in Windsor

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →